CAR T
Showing of 16 results
From Lab to Life: Expanding the Power of CAR T-Cells
Explore the rapidly evolving world of CAR T-cell therapy and how scientists are reengineering the immune system to fight disease. Drs. David Wald and Reshmi Parameswaran discuss the design, manufacturing, and expanding use beyond blood cancers.
Breaking Into the Brain: Overcoming Barriers to Understand Autism and Brain Tumors
Matthew Anderson, MD, PhD, and Tyler Miller, MD, PhD, discuss how immune biology is reshaping neuroscience - from autism and obesity to CAR T cell therapies for glioblastoma and the challenge of crossing the blood brain barrier.
Multiple Myeloma Patients at UH Seidman Cancer Center Have New Immunotherapy Option
BAFF CAR T has important advantage for these patients - Innovations in Cancer | July 2024
UH Seidman Researchers Slash Time Needed to Produce CAR T-Cells
Quicker process will get needed therapy to cancer patients who don’t have time to wait - Innovations in Cancer | Fall 2022
Novel Strategy to Improve CAR T-cell Efficacy in Non-Hodgkin Lymphoma Revealed in Preclinical Studies
University Hospitals Seidman Cancer Center researchers part of team finding blocking a single receptor may combat T cell dysfunction associated with poor response to therapy - Innovations in Cancer | Summer 2022
Team Led by UH Seidman Cancer Center Researcher Develops and Validates Three-in-One CAR T Therapy
Approach detailed in the journal Nature Communications shows therapeutic potential of BAFF CAR T for treating multiple B cell cancers, using mouse models with high effectiveness and minimum side effects - Innovations in Cancer | Winter 2022